Business, Environment, Media & Communications, Science, Technology, Travel & Venues

AST SpaceMobile announces definitive commercial agreement with Verizon to support space-based cellular broadband across the Continental United States

Agreement to provide space-based direct-to-device connectivity to everyday cell phones further expands strategic partnership announced in May 2024   MIDLAND, Texas — (BUSINESS WIRE) — $ASTS #AST—AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular

Cultural Corner, Education, Environment, Local News, Media & Communications, Science, Technology

Launch across America returns: ARM & HAMMER™ Baking Soda Rocket Day prepares for take-off on Oct. 9

The second annual nationwide educational celebration inspires students to reach for the stars with hands-on science, space-themed fun, and baking soda rocket launches across the country.   EWING, N.J. — (BUSINESS WIRE) — Building on the success of its inaugural 2024 educational

Health Care, Media & Communications, Money & Financial, Science, Technology

Digital Medicine Society unveils Healthcare 2030 on Sept. 22, as blueprint to transform US healthcare in the digital era

Launch coincides with the Healthcare 2030 Summit in Washington, DC, bringing together top government officials, industry leaders, and patient advocates BOSTON — PRNewswire — On Monday, earlier this morning, the Digital Medicine Society (DiMe) released Healthcare 2030: An Impact Thesis for the Digital Era of Medicine, a practical

Cultural Corner, Health Care, Law & Legal, Science

Invisible Wounds Foundation launches Brain Health Collaborative to combat traumatic brain injury in service members and to prevent military suicides

CHICAGO — PRNewswire — In advance to the 24th anniversary of 9-11, the Invisible Wounds Foundation, on Monday, announced the launch of its Brain Health Collaborative. The Invisible Wounds Foundation is a Chicago-based nonprofit foundation dedicated to advancing the science to diagnose, treat,

Health Care, Law & Legal, Lifestyle, Science

VANDA Pharmaceuticals recently announces FDA grants Orphan Drug Designation for VGT-1849B, a novel and selective candidate for the treatment of Polycythemia Vera

WASHINGTON — PRNewswire — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) on Aug. 28, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849B, a selective peptide nucleic acid-based JAK2 inhibitor for the treatment of polycythemia vera (PV).